Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis

Mise à jour : Il y a 4 ans
Référence : NCT01118728

Femme et Homme

Extrait

Primary Objective: - To assess the long term safety of Sarilumab (SAR153191/REGN88) in patients with ankylosing spondylitis (AS) Secondary Objective: - To assess the long term efficacy of Sarilumab (SAR153191/REGN88) in patients with AS


Critère d'inclusion

  • Ankylosing spondylitis


Liens